REPORT ID 4014

Global Insomnia Medication Market Research Report 2017

Publish Date
15-Dec-17
Pages
113
Format
Electronic (PDF)

In this report, the global Insomnia Medication market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Insomnia Medication in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Insomnia Medication market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Eisai
    Merck
    Pfizer
    Sanofi
    Takeda
    Vanda Pharmaceuticals
    Astellas
    Dainippon Sumitomo
    ECR Pharmaceuticals (Valeant)
    Flynn Pharma
    Johnson & Johnson
    Meda
    Somnus Therapeutics
    Purdue Pharma
    Neurim
    Minerva Neurosciences
    Pernix Therapeutics
    SkyePharma
    Paratek Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Nonbenzodiazepine Receptor Agonists
    Benzodiazepine Receptor Agonists
    The Selective Melatonin Receptor Agonist Ramelteon
    Sedating Antidepressants
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Adults
    Kids

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Insomnia Medication Market Research Report 2017
1 Insomnia Medication Market Overview
    1.1 Product Overview and Scope of Insomnia Medication
    1.2 Insomnia Medication Segment by Type (Product Category)
        1.2.1 Global Insomnia Medication Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Insomnia Medication Production Market Share by Type (Product Category) in 2016
        1.2.3 Nonbenzodiazepine Receptor Agonists
        1.2.4 Benzodiazepine Receptor Agonists
        1.2.5 The Selective Melatonin Receptor Agonist Ramelteon
        1.2.6 Sedating Antidepressants
    1.3 Global Insomnia Medication Segment by Application
        1.3.1 Insomnia Medication Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Adults
        1.3.3 Kids
    1.4 Global Insomnia Medication Market by Region (2012-2022)
        1.4.1 Global Insomnia Medication Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Insomnia Medication (2012-2022)
        1.5.1 Global Insomnia Medication Revenue Status and Outlook (2012-2022)
        1.5.2 Global Insomnia Medication Capacity, Production Status and Outlook (2012-2022)

2 Global Insomnia Medication Market Competition by Manufacturers
    2.1 Global Insomnia Medication Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Insomnia Medication Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Insomnia Medication Production and Share by Manufacturers (2012-2017)
    2.2 Global Insomnia Medication Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Insomnia Medication Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Insomnia Medication Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Insomnia Medication Market Competitive Situation and Trends
        2.5.1 Insomnia Medication Market Concentration Rate
        2.5.2 Insomnia Medication Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Insomnia Medication Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Insomnia Medication Capacity and Market Share by Region (2012-2017)
    3.2 Global Insomnia Medication Production and Market Share by Region (2012-2017)
    3.3 Global Insomnia Medication Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Insomnia Medication Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Insomnia Medication Consumption by Region (2012-2017)
    4.2 North America Insomnia Medication Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Insomnia Medication Production, Consumption, Export, Import (2012-2017)
    4.4 China Insomnia Medication Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Insomnia Medication Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Insomnia Medication Production, Consumption, Export, Import (2012-2017)
    4.7 India Insomnia Medication Production, Consumption, Export, Import (2012-2017)

5 Global Insomnia Medication Production, Revenue (Value), Price Trend by Type
    5.1 Global Insomnia Medication Production and Market Share by Type (2012-2017)
    5.2 Global Insomnia Medication Revenue and Market Share by Type (2012-2017)
    5.3 Global Insomnia Medication Price by Type (2012-2017)
    5.4 Global Insomnia Medication Production Growth by Type (2012-2017)

6 Global Insomnia Medication Market Analysis by Application
    6.1 Global Insomnia Medication Consumption and Market Share by Application (2012-2017)
    6.2 Global Insomnia Medication Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Insomnia Medication Manufacturers Profiles/Analysis
    7.1 Eisai
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Insomnia Medication Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Eisai Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Merck
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Insomnia Medication Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Merck Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Pfizer
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Insomnia Medication Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Pfizer Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Sanofi
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Insomnia Medication Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Sanofi Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Takeda
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Insomnia Medication Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Takeda Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Vanda Pharmaceuticals
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Insomnia Medication Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Vanda Pharmaceuticals Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Astellas
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Insomnia Medication Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Astellas Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Dainippon Sumitomo
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Insomnia Medication Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Dainippon Sumitomo Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 ECR Pharmaceuticals (Valeant)
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Insomnia Medication Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Flynn Pharma
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Insomnia Medication Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Flynn Pharma Insomnia Medication Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Johnson & Johnson
    7.12 Meda
    7.13 Somnus Therapeutics
    7.14 Purdue Pharma
    7.15 Neurim
    7.16 Minerva Neurosciences
    7.17 Pernix Therapeutics
    7.18 SkyePharma
    7.19 Paratek Pharmaceuticals

8 Insomnia Medication Manufacturing Cost Analysis
    8.1 Insomnia Medication Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Insomnia Medication

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Insomnia Medication Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Insomnia Medication Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Insomnia Medication Market Forecast (2017-2022)
    12.1 Global Insomnia Medication Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Insomnia Medication Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Insomnia Medication Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Insomnia Medication Price and Trend Forecast (2017-2022)
    12.2 Global Insomnia Medication Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Insomnia Medication Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Insomnia Medication Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Insomnia Medication Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Insomnia Medication Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Insomnia Medication Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Insomnia Medication Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Insomnia Medication Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Insomnia Medication Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer